Market Overview:
The global continuous glucose monitoring market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in continuous glucose monitoring devices, and rising awareness about diabetes management. The global continuous glucose monitoring market is segmented on the basis of type into wearable and implantable devices. The implantable devices segment is expected to grow at a higher CAGR than the wearable devices segment during the forecast period from 2018 to 2030. This can be attributed to factors such as increasing preference for minimally invasive procedures, growing demand for real-time blood sugar tracking, and rising incidence of chronic diseases such as diabetes. On the basis of application, the global continuous glucose monitoring market is divided into child, adult, and elderly segments.
Product Definition:
Continuous Glucose Monitoring (CGM) is a method of monitoring blood glucose levels on a 24-hour basis. A sensor is worn by the patient and transmits blood sugar readings to a monitor which records and graphs the data. This allows for more accurate detection of trends and patterns in blood sugar levels, as well as early detection of potential problems. CGM can be used by people with diabetes to adjust their insulin doses, or by pregnant women with gestational diabetes mellitus to help control their blood sugar levels.
Wearable:
The global wearable market size was valued at USD 2.64 billion in 2015 and is expected to witness a growth of over 50% by 2022, owing to the increasing adoption of these devices among patients suffering from diabetes. The rising geriatric population base worldwide is also one of the key factors driving demand for continuous glucose monitoring (CGM) devices as they are prone to various chronic conditions such as diabetes and cardiovascular diseases that require constant monitoring.
Implantable:
Implantable CGM devices are small glucose sensors that are surgically inserted into the body. These devices can wirelessly communicate with a handheld device called a reader. The data obtained from these readers is used to provide information regarding blood sugar levels and also helps in monitoring the effects of any medication taken by patients suffering from diabetes mellitus.
Application Insights:
The application segment is segregated into three sub-segments, namely child, adult and elderly. The continuous glucose monitoring devices for use in the treatment of diabetes are primarily aimed at improving the glycemic control in patients with diabetes. Hence, this application segment is expected to dominate the market throughout the forecast period owing to increasing incidence of diabetes worldwide.
The CGM devices for use in type 1 and type 2 diabetic patients are gaining significant momentum due to their ability to provide real-time data on a patient¢â‚¬â„¢s blood glucose levels without requiring any fingerstick test every few days. Moreover, these devices help reduce hypoglycemia unawareness by providing early warning signs of low blood sugar levels which helps avoid potential complications associated with hypoglycemia such as brain damage or seizure among others. Thus, rising prevalence of diabetes coupled with technological advancements that have improved accuracy and sensitivity further drive its demand globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to technological advancements, high healthcare expenditure, and increasing prevalence of diabetes in this region. Moreover, a rise in awareness about CGM systems and their benefits is also one of the major factors responsible for maintaining North America’s dominance over other regions during the forecast period.
Asia Pacific is anticipated to witness significant growth over the next eight years owing to rising diabetic population coupled with growing investments by prominent players for expansion of their business operations within this region. In addition, improving economic conditions are also likely to contribute toward regional growth through increased disposable income that will enable people afflicted with diabetes manage their condition better thereby boosting demand for CGMs over time (Kumar & Parikh 2016). Furthermore, China has been observed as one of the countries having a large number of patients suffering from type-2 diabetes (Zhang et al., 2015).
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for continuous glucose monitoring devices in the coming years.
- Growing awareness about benefits of continuous glucose monitoring: There is a growing awareness among people about the benefits of using continuous glucose monitoring devices. This is likely to boost the demand for these devices in the near future.
- Technological advancements: Continuous glucose monitoring technology is constantly evolving, with new and innovative products being launched in the market on a regular basis. This will help fuel growth of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Continuous Glucose Monitoring Market Research Report
By Type
Wearable, Implantable
By Application
Child, Adult, Elderly
By Companies
Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Roche, Terumo, POCTech, Dexcom
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Continuous Glucose Monitoring Market Report Segments:
The global Continuous Glucose Monitoring market is segmented on the basis of:
Types
Wearable, Implantable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Child, Adult, Elderly
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dexcom
- Abbott Laboratories
- Medtronic
- Senseonics Holdings
- GlySens Incorporated
- Roche
- Terumo
- POCTech
- Dexcom
Highlights of The Continuous Glucose Monitoring Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wearable
- Implantable
- By Application:
- Child
- Adult
- Elderly
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Continuous Glucose Monitoring Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Continuous glucose monitoring (CGM) is a type of diabetes care in which a person wears a sensor on their body that continuously measures blood sugar levels. CGM can help people with diabetes manage their blood sugar levels more effectively by providing real-time information about how well they are controlling their disease.
Some of the major companies in the continuous glucose monitoring market are Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Roche, Terumo, POCTech, Dexcom.
The continuous glucose monitoring market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Glucose Monitoring Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Glucose Monitoring Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Glucose Monitoring Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Glucose Monitoring Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Glucose Monitoring Market Size & Forecast, 2020-2028
4.5.1 Continuous Glucose Monitoring Market Size and Y-o-Y Growth
4.5.2 Continuous Glucose Monitoring Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Wearable
5.2.2 Implantable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Child
6.2.2 Adult
6.2.3 Elderly
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Continuous Glucose Monitoring Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Glucose Monitoring Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Wearable
9.6.2 Implantable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Child
9.10.2 Adult
9.10.3 Elderly
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Wearable
10.6.2 Implantable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Child
10.10.2 Adult
10.10.3 Elderly
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Wearable
11.6.2 Implantable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Child
11.10.2 Adult
11.10.3 Elderly
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Wearable
12.6.2 Implantable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Child
12.10.2 Adult
12.10.3 Elderly
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Wearable
13.6.2 Implantable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Child
13.10.2 Adult
13.10.3 Elderly
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Continuous Glucose Monitoring Market: Competitive Dashboard
14.2 Global Continuous Glucose Monitoring Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dexcom
14.3.2 Abbott Laboratories
14.3.3 Medtronic
14.3.4 Senseonics Holdings
14.3.5 GlySens Incorporated
14.3.6 Roche
14.3.7 Terumo
14.3.8 POCTech
14.3.9 Dexcom
